Jenburkt Pharmaceuticals Share Price

    BSE
    1325
    -27.55 (2.02%)
    JENBURPH • 02 Jul, 2025 | 10:15 AM
    BUY

    1Y Annualised Return

    53.66%

    3Y Annualised Return

    38.43%

    5Y Annualised Return

    29.82%

    The current prices are delayed, login or Open Demat Account for live prices.

    Jenburkt Pharmaceuticals Stock Performance

    1W Return2.79
    1Y Return50.53
    Today's Low1322
    Prev. Close1,352.55
    Mkt Cap (Cr.)596.92
    1M Return15.83
    3Y Return171.96
    52-Week High1386
    Open1,386.00
    PE Ratio18.97
    6M Return3.82
    Today's High1386
    52-Week Low815.8
    Face Value10

    Jenburkt Pharmaceuticals Company background

    Founded in: 1985
    Managing director: Ashish U Bhuta
    Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation caters to government, semigovernment institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at SihorGujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements. In addition, it has a Research Development unit duly approved by the Ministry of Science Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market.The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, lifechanging therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company.In 202122, the Company launched a new OTC division Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 202223.

    As of 02 Jul, 2025, Jenburkt Pharmaceuticals share price is ₹1325. The stock opened at ₹1386 and had closed at ₹1352.6 the previous day. During today’s trading session, Jenburkt Pharmaceuticals share price moved between ₹1,322.00 and ₹1,386.00, with an average price for the day of ₹1354.00. Over the last 52 weeks, the stock has recorded a low of ₹815.80 and a high of ₹1,386.00. In terms of performance, Jenburkt Pharmaceuticals share price has increased by 8.6% over the past six months and has increased by 53.66% over the last year.

    Read More
    Jenburkt Pharmaceuticals SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years

    Total Investment of ₹65,00,000

    Would have become ₹86,08,934 (+32.45%)

    Daily SIP of 25,000 would have become 86,08,934 in 1 year with a gain of 21,08,934 (+32.45%)

    View details of Market Depth

    Jenburkt Pharmaceuticals Fundamental

    Market Cap (in crs)

    596.92

    Face Value

    10

    Turnover (in lacs)

    3.83

    Key Metrics

    Qtr Change %
    New 52W High today
    29.8
    Dividend yield 1yr %
    Below industry Median
    1.2

    Top Mutual Fund Invested in Jenburkt Pharmaceuticals

    Promoter
    46.7%
    Domestic Institutions
    0.1%
    Public
    53.2%
    Promoter
    46.7%
    Domestic Institutions
    0.1%
    Public
    53.2%
    Promoter
    46.7%
    Public
    53.3%
    Promoter
    46.7%
    Public
    53.3%
    Promoter
    47.2%
    Public
    52.8%
    Promoter
    47.4%
    Public
    52.6%

    Jenburkt Pharmaceuticals Technical Analysis

    Moving Averages Analysis
    1325
    Current Price
    Bullish Moving Averages
    14
    Bearish Moving Averages
    2
    5Day EMA
    1,336.00
    10Day EMA
    1,320.60
    12Day EMA
    1,314.80
    20Day EMA
    1,289.00
    26Day EMA
    1,269.30
    50Day EMA
    1,209.10
    100Day EMA
    1,155.60
    200Day EMA
    1,099.60
    5Day SMA
    1,327.70
    10Day SMA
    1,316.80
    20Day SMA
    1,307.70
    30Day SMA
    1,257.10
    50Day SMA
    1,172.80
    100Day SMA
    1,099.40
    150Day SMA
    1,142.80
    200Day SMA
    1,127.50
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    541 Rs
    680 Rs
    Week Rs
    979 Rs
    1232 Rs
    Month Rs
    1741 Rs
    2185 Rs
    1,357.55
    Pivot
    Resistance
    First Resistance
    1,375
    Second Resistance
    1,397.45
    Third Resistance
    1,414.90
    Support
    First Support
    1,335.10
    Second support
    1,317.65
    Third Support
    1,295.20
    Relative Strength Index
    65.89
    Money Flow Index
    80.81
    MACD
    45.56
    MACD Signal
    48.09
    Average True Range
    51.79
    Average Directional Index
    33.27
    Rate of Change (21)
    18.24
    Rate of Change (125)
    12.43

    Jenburkt Pharmaceuticals Latest News

    23 JUN 2025 | Monday

    Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    20 JUN 2025 | Friday

    Jenburkt Pharmaceuticals Ltd - 524731 - Intimation Of Record Date And Cut-Off Date

    20 JUN 2025 | Friday

    Jenburkt Pharmaceuticals Ltd - 524731 - Notice Of The 40Th Annual General Meeting Of The Company Schedule To Be Held On Friday, 18Th July, 2025 Through VC/OAVM.

    View More

    Jenburkt Pharmaceuticals Share Price FAQs

    You can easily buy Jenburkt Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Jenburkt Pharmaceuticals share price is ₹1386 and ₹815.8 as of 2/7/2025.

    Please be aware that Jenburkt Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    816.90
    -3.40 (-0.41%)
    1,519.70
    -8.70 (-0.57%)
    2,000.50
    -11.60 (-0.58%)
    1,644.90
    +38.10 (+2.37%)
    3,475.00
    +45.30 (+1.32%)
    Top Gainers
    1,631.80
    +25.00 (+1.56%)
    3,458.80
    +29.10 (+0.85%)
    266.60
    +2.05 (+0.77%)
    2,034.90
    +15.50 (+0.77%)
    1,035.80
    +6.20 (+0.60%)
    Top Losers
    849.00
    -30.10 (-3.42%)
    798.45
    -11.45 (-1.41%)
    687.45
    -9.00 (-1.29%)
    6,068.50
    -75.50 (-1.23%)
    2,029.90
    -23.90 (-1.16%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -